Cargando…
Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offeri...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223368/ https://www.ncbi.nlm.nih.gov/pubmed/37242072 http://dx.doi.org/10.3390/nano13101656 |
_version_ | 1785049925074026496 |
---|---|
author | Acter, Shahinur Moreau, Michele Ivkov, Robert Viswanathan, Akila Ngwa, Wilfred |
author_facet | Acter, Shahinur Moreau, Michele Ivkov, Robert Viswanathan, Akila Ngwa, Wilfred |
author_sort | Acter, Shahinur |
collection | PubMed |
description | In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offering a range of extraordinary inherent advantages. These include excellent drug loading capability, photothermal conversion efficiency, and adhesive properties. Though the mechanism of dopamine polymerization remains unclear, PDA has demonstrated exceptional flexibility in engineering desired morphology and size, easy and straightforward functionalization, etc. Moreover, it offers enormous potential for designing multifunctional nanomaterials for innovative approaches in cancer treatment. The aim of this work is to review studies on PDA, where the potential to develop multifunctional nanomaterials with applications in photothermal therapy has been demonstrated. Future prospects of PDA for developing applications in enhancing radiotherapy and/or immunotherapy, including for image-guided drug delivery to boost therapeutic efficacy and minimal side effects, are presented. |
format | Online Article Text |
id | pubmed-10223368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102233682023-05-28 Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment Acter, Shahinur Moreau, Michele Ivkov, Robert Viswanathan, Akila Ngwa, Wilfred Nanomaterials (Basel) Review In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offering a range of extraordinary inherent advantages. These include excellent drug loading capability, photothermal conversion efficiency, and adhesive properties. Though the mechanism of dopamine polymerization remains unclear, PDA has demonstrated exceptional flexibility in engineering desired morphology and size, easy and straightforward functionalization, etc. Moreover, it offers enormous potential for designing multifunctional nanomaterials for innovative approaches in cancer treatment. The aim of this work is to review studies on PDA, where the potential to develop multifunctional nanomaterials with applications in photothermal therapy has been demonstrated. Future prospects of PDA for developing applications in enhancing radiotherapy and/or immunotherapy, including for image-guided drug delivery to boost therapeutic efficacy and minimal side effects, are presented. MDPI 2023-05-17 /pmc/articles/PMC10223368/ /pubmed/37242072 http://dx.doi.org/10.3390/nano13101656 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Acter, Shahinur Moreau, Michele Ivkov, Robert Viswanathan, Akila Ngwa, Wilfred Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title | Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title_full | Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title_fullStr | Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title_full_unstemmed | Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title_short | Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment |
title_sort | polydopamine nanomaterials for overcoming current challenges in cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223368/ https://www.ncbi.nlm.nih.gov/pubmed/37242072 http://dx.doi.org/10.3390/nano13101656 |
work_keys_str_mv | AT actershahinur polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment AT moreaumichele polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment AT ivkovrobert polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment AT viswanathanakila polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment AT ngwawilfred polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment |